Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Buyout expectations

The important part is the "indirect ownership" because it means that several parties can not be buying, yet each maintaining a sub-10% level, with the intent to buy out PTSC, without being in breach of the Regulations.

 

 

Be well

Share
New Message
Please login to post a reply